ProfileGDS5822 / ILMN_1243717
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 18% 31% 30% 59% 12% 51% 47% 53% 28% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.518
GSM1276600PDAC Late Ablation Control 217.631
GSM1276601PDAC Late Ablation Control 310.230
GSM1276602PDAC Late Ablation 124.759
GSM1276603PDAC Late Ablation 29.412
GSM1276604PDAC Late Ablation 325.151
GSM1303940PDAC Late Ablation_anti-CTLA4 120.947
GSM1303941PDAC Late Ablation_anti-CTLA4 228.253
GSM1303942PDAC Late Ablation_anti-CTLA4 313.928